TMCnet News
Lowest Forward Earnings Yield in the Pharmaceuticals Industry Detected in Shares of Depomed (DEPO, AUXL, FRX, VPHM, OMPI)Apr 24, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the lowest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Generally, the higher the earnings yield, the more undervalued the stock.Depomed ranks lowest with a forward earnings yield of 0.3%. Following is Auxilium Pharmaceuticals with a forward earnings yield of 0.4%. Forest Laboratories ranks third lowest with a forward earnings yield of 1.1%. Viropharma follows with a forward earnings yield of 2.4%, and Obagi Medical Products rounds out the bottom five with a forward earnings yield of 3.2%. SmarTrend recommended that subscribers consider buying shares of Obagi Medical Products on March 15th, 2013 as our technology indicated a new Uptrend was in progress when shares hit $14.72. Since that recommendation, shares of Obagi Medical Products have risen 62.7%. We continue to monitor Obagi Medical Products for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |